![The Pharmaceutical Journal on Twitter: "GlaxoSmithKline revises colour and labelling of Relvar Ellipta inhaler http://t.co/QWxnpG3RTm http://t.co/IYC7sT7b2E" / Twitter The Pharmaceutical Journal on Twitter: "GlaxoSmithKline revises colour and labelling of Relvar Ellipta inhaler http://t.co/QWxnpG3RTm http://t.co/IYC7sT7b2E" / Twitter](https://pbs.twimg.com/media/B4qAXeiCEAAgHOm.jpg)
The Pharmaceutical Journal on Twitter: "GlaxoSmithKline revises colour and labelling of Relvar Ellipta inhaler http://t.co/QWxnpG3RTm http://t.co/IYC7sT7b2E" / Twitter
![Positive Results for Relvar® Ellipta® Lung Function Study in Patients with Well-Controlled Asthma - EMG Positive Results for Relvar® Ellipta® Lung Function Study in Patients with Well-Controlled Asthma - EMG](https://emj.emg-health.com/wp-content/uploads/sites/2/2017/05/Relvar-Ellipta-Significantly...-940x566.jpg)
Positive Results for Relvar® Ellipta® Lung Function Study in Patients with Well-Controlled Asthma - EMG
![GSK's Breo approved in Europe, COPD market may be underestimated - MM+M - Medical Marketing and Media GSK's Breo approved in Europe, COPD market may be underestimated - MM+M - Medical Marketing and Media](https://www.mmm-online.com/wp-content/uploads/sites/2/2018/07/breo_7_-_trade-opened-inhaler-_496393.jpg)
GSK's Breo approved in Europe, COPD market may be underestimated - MM+M - Medical Marketing and Media
![Relvar Ellipta 92micrograms/dose / 22micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) 30 dose - RightBreathe Relvar Ellipta 92micrograms/dose / 22micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) 30 dose - RightBreathe](https://www.rightbreathe.com/wp-content/uploads/2016/06/Relvar-92-22-Device-Front-Closed.jpg)